FDA’s March 25 warning letter to Skin Authority, LLC offers another illustration of the types of cosmetics claims in the agency’s crosshairs and the challenge skin-care brands face in marketing their products competitively without overstepping regulatory boundaries.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?